Home > Food & Beverages > Nutraceuticals > Herbal Supplements > Indian Ginseng Market

Indian Ginseng Market Analysis

  • Report ID: GMI7221
  • Published Date: Nov 2023
  • Report Format: PDF

Ashwagandha Market Analysis

Based on Type, the KSM 66 type segment held over USD 192.8 million revenue in 2022. KSM-66, renowned for its high potency and standardized composition, holds a significant market share owing to its widespread application in pharmaceutical and nutraceutical products. With its emphasis on maintaining the full spectrum of bioactive constituents, KSM-66 has gained traction among consumers seeking potent and reliable Ashwagandha-based supplements. Sensoril, recognized for its stress-reducing and mood-enhancing properties, also commands a substantial market share, particularly in the wellness and personal care sectors.

 

 Ashwagandha Market Revenue Share, By Product Type, (2022)

Based on Product Type, the ashwagandha root products segment accounted for 67.99% of the ashwagandha market share in 2022, due to the wide recognition of the root's medicinal properties, including stress reduction, immune system enhancement, and anti-inflammatory benefits. The robust demand for these products stems from the traditional use of ashwagandha roots in Ayurvedic medicine and the increasing consumer awareness of their health benefits.

 

 

Based on Form, the ashwagandha market from powder form segment will gain remarkable momentum during the forecast timeline. Ashwagandha powder is known for its versatility and ease of incorporation into various food and beverage products. It caters to the rising demand for functional ingredients in the wellness and dietary supplement industries. Its adaptability in different culinary preparations and the convenience it offers in customized dosing have contributed to its widespread popularity among health-conscious consumers. Ashwagandha capsules, encapsulating the herb's therapeutic properties in convenient and standardized doses, constitute a substantial portion of the market share, appealing to consumers seeking hassle-free consumption and precise dosage control.
 

Based on Function, the ashwagandha market is segmented as Improved stamina, Improved immunity, Overall wellbeing, Reduced anxiety and stress, Brain health, Muscle strength and Others. Improved stamina held the dominant market in 2022 and is anticipated to grow through the years. Improved stamina function caters to fitness enthusiasts and individuals seeking performance-boosting solutions. The growing interest in natural supplements for physical endurance, cognitive enhancement, and muscle recovery has led to an increased demand for Ashwagandha products tailored to these specific functions.
 

Asia Pacific Ashwagandha Market Size, 2020- 2032 (USD Million)

Asia Pacific ashwagandha market size dominated around USD 225.9 million in 2022. With a rich cultural heritage deeply rooted in the use of botanical remedies, the Asia Pacific region holds a substantial market share in the production and consumption of Ashwagandha. Countries such as India, the birthplace of Ayurveda, and Nepal have been pivotal in the cultivation and processing of high-quality Ashwagandha, leveraging their indigenous knowledge and expertise to meet both domestic and international demand.
 

The widespread acceptance of Ayurvedic principles and the increasing awareness of the health benefits associated with Ashwagandha have fueled the regional market growth, with consumers incorporating Ashwagandha-based products into their daily wellness routines. Additionally, the presence of established herbal medicine industries and the prevalence of holistic healthcare practices in countries across the Asia Pacific region have contributed to the continuous expansion of the market.

Authors: Kiran Pulidindi, Himanshu Kabra

Frequently Asked Questions (FAQ) :

The market size of the Indian ginseng reached USD 641 million in 2022 and is set to surpass USD 1.18 billion by 2032, owing to the rising consumer preference for natural and herbal supplements along with the growing awareness of its various health benefits.

The Indian ginseng industry from the KSM 66 segment generated USD 192.8 million in revenue in 2022, due to its high potency and standardized composition leading to its rising application in pharmaceutical and nutraceutical products.

Asia Pacific ashwagandha market was worth USD 225.9 million in 2022, attributed to the rich cultural heritage of the region which is deeply rooted in the use of botanical remedies.

Some of the top companies engaged in the market are KSM-66 Ashwagandha, Sensoril Ashwagandha, Ashwagandha Research & Development, Arjuna Natural Extracts, Sabinsa Corporation, Himalaya Global Holdings, Dabur India, Amway India, Sri Sri Ayurveda, Patanjali Ayurved, and Herbalife Nutrition.

Indian Ginseng Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 245
  • Countries covered: 21
  • Pages: 210
 Download Free Sample